
KL-50 in post TMZ MMR-deficient GBM
Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurr...
22 Helmi 202521min

Measurable disease per FET-PET vs MRI in GBM
Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based ...
8 Helmi 202514min

Pre-radiation chemotherapy in GBM
Dr. Iyad Alnahhas interviews Dr. Danielle Bazer about her and her team's recently published manuscript, entitled: Using a Pre-Radiation Window to Identify Potentially Active Cytotoxic Agents in Adults...
20 Tammi 202513min

cIMPACT-NOW Update 8: grading of meningiomas
Dr. Rachna Malani interviews Drs. Felix Sahm and Arie Perry about their recent manuscript entitled: "cIMPACT-NOW Update 8: Clarifications on molecular risk parameters and recommendations for WHO gradi...
13 Joulu 202443min

Residual tumor volume and survival after CCNU/TMZ in GBM
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival ...
24 Marras 202413min

Alterations in RNA splicing between meningioma DNA methylation groups
Dr. Evan Noch interviews Drs. Nathan Leclair, David Raleigh and Olga Anczukow about their recent manuscript entitled: "RNA splicing as a biomarker and phenotypic driver of meningioma DNA methylation g...
8 Marras 202433min

The immune landscape of IDH mutant and IDHwt glioma
Dr. Evan Noch interviews Drs. Pravesh Gupta and Krishna Bhat about their recent manuscript entitled "Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas", publi...
25 Loka 202433min

Equity-driven applications of AI in neuro-oncology
Dr. Iyad Alnahhas interviews Dr. Mulki Mehari about her and her team's recent manuscript entitled: "Enhancing neuro-oncology care through equity-driven applications of artificial intelligence", publis...
9 Loka 202422min











